文献速递术前评估与围术期医学

膀胱切除术患者容量替代治疗中平衡6%羟乙基淀粉(130/0.4)与5%白蛋白对肾功能无差异:一项随机对照试验

No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial.
PubMed 文献 · Anesthesiology · 2018-01-01

主要终点为术后第90天与术前首次访视血清胱抑素C比值,两组中位数差异为0.03(95%CI -0.09至0.08,P=0.165),无显著差异。结论认为在非危重大手术患者中两者肾脏安全性相当。

要点

  • 在非危重膀胱切除术患者中,5%白蛋白与平衡6%羟乙基淀粉(130/0.4)对肾功能影响无显著差异。
  • 主要终点胱抑素C比值组间中位差异0.03(95%CI -0.09至0.08,P=0.165)。
  • 次要终点eGFR、NGAL及RIFLE标准在两组间亦无显著差异。

核心结论

  • 就肾功能和肾损伤而言,5%白蛋白与平衡6%羟乙基淀粉(130/0.4)在非危重大手术患者中具有可比的安全性。

主要发现

  • 主要终点胱抑素C比值(术后第90天/术前首次访视)中位数:白蛋白组1.11(IQR 1.01-1.23),羟乙基淀粉组1.08(IQR 1.00-1.20),中位差异0.03(95%CI -0.09至0.08,P=0.165)。
  • 血清胱抑素C浓度、估算肾小球滤过率、RIFLE标准及中性粒细胞明胶酶相关脂质运载蛋白在两组间均无显著差异。
  • 两组输液需求、输血率和围术期血流动力学相似。

临床怎么用

  • 在非危重泌尿外科大手术患者中,平衡6%羟乙基淀粉(130/0.4)可作为5%白蛋白的替代胶体用于围术期容量替代,肾功能安全性相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of artificial colloids has declined in critical care, whereas they are still used in perioperative medicine. Little is known about the nephrotoxic potential in noncritically ill patients during routine surgery. The objective of this trial was to evaluate the influences of albumin 5% and balanced hydroxyethyl starch 6% (130/0.4) on renal function and kidney injury. METHODS: One hundred urologic patients undergoing elective cystectomy were randomly assigned for this prospective, single-blinded, controlled study with two parallel groups to receive either albumin 5% or balanced hydroxyethyl starch 6% (130/0.4) as the only perioperative colloid. The primary endpoint was the ratio of serum cystatin C between the last visit at day 90 and the first preoperative visit. Secondary endpoints were estimated glomerular filtration rate and serum neutrophil gelatinase-associated lipocalin until the third postoperative day and risk, injury, failure, loss, and end-stage renal disease criteria at postoperative days 3 and 90. RESULTS: The median cystatin C ratio was 1.11 (interquartile range, 1.01 to 1.23) in the albumin and 1.08 (interquartile range, 1.00 to 1.20) in the hydroxyethyl starch group (median difference = 0.03; 95% CI, -0.09 to 0.08; P = 0.165). Also, there were no significant differences concerning serum cystatin C concentrations; estimated glomerular filtration rate; risk, injury, failure, loss, and end-stage renal disease criteria; and neutrophil gelatinase-associated lipocalin. Infusion requirements, transfusion rates, and perioperative hemodynamics were similar in both groups. CONCLUSIONS: With respect to renal function and kidney injury, this study indicates that albumin 5% and balanced hydroxyethyl starch 6% have comparable safety profiles in noncritically ill patients undergoing major surgery.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Kammerer T, Brettner F, Hilferink S, et al. No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial. Anesthesiology. 2018. PMID: 29064872. doi:10.1097/ALN.0000000000001927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。